Guillan-Barre: An Infrequent Presentation After Kidney Transplantation (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO1196; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received induction with Thymoglobulin 4.5 mg/kg and was maintained on Tacrolimus (goal trough 8-10 ng/mL) and Mycophenolate Mofetil 1000 mg BID...Given recurrence, CNI minimization pursued with transition to Belatacept...In our case, IGM and C1Q presence on IF may suggest an autoimmune response to antigens on podocytes and peripheral nerves given recurrent symptoms and increased proteinuria. Future studies for more directed treatment are necessary to ensure favorable outcomes."
Chronic Kidney Disease • Complement-mediated Rare Disorders • Diabetic Nephropathy • Focal Segmental Glomerulosclerosis • Gastroenterology • Gastrointestinal Disorder • Glomerulonephritis • Immunology • Infectious Disease • Nephrology • Solid Organ Transplantation • Transplantation
|